VEGFA and retinal vasculitis: Recently, cases of IOI with occlusive vasculitis associated with faricimab have been reported in eyes that underwent anti-VEGF therapy.12,13 Based on the data available as of the end of August 2023, the estimated reported rate of retinal vasculitis with occlusion is 0.06 cases per 10 000 injections of faricimab.14,15